Edwards Lifesciences Corp (EW)

Days of sales outstanding (DSO)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Receivables turnover		7.74	8.34	8.96	8.52	7.97
DSO	days	47.17	43.77	40.72	42.86	45.79

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 7.74
= 47.17

The days of sales outstanding (DSO) for Edwards Lifesciences Corp have shown some fluctuation over the past five years. In 2023, the DSO increased to 50.87 days from 47.41 days in 2022. This indicates that, on average, it took the company approximately 50.87 days to collect its accounts receivable in 2023.

Comparing to previous years, the DSO was slightly higher in 2021 at 46.38 days, and it also increased from 50.16 days in 2020. In 2019, the DSO was similar to 2020 at 50.29 days.

Overall, the trend in DSO for Edwards Lifesciences Corp is showing some variability with a recent increase in 2023 compared to the previous year. A higher DSO could indicate potential issues with collecting accounts receivable efficiently, which may impact cash flow and working capital management. Monitoring this metric over time can provide insights into the company's accounts receivable management effectiveness.